Thus, although further work will be required to gain a complete understanding of how H2A.Z functionally interacts with various histone modifications, these findings nevertheless illustrate that H2A.Z overexpression in bladder cancer cells is likely to act in concert with active histone modifications which establish constitutive expression of the target genes. This evidence concerns the gene H2AZ1 and urinary bladder cancer.